SCHEMBL5481572

SCHEMBL5481572

CCOC(=O)CC(=O)CSc1cccc(OC)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.46
HSD17B10 Q99714 8/20 0.46
KDM4E B2RXH2 8/20 0.46
GAA P10253 2/20 0.46
MEN1 O00255 7/20 0.46
KMT2A Q03164 7/20 0.46
NPSR1 Q6W5P4 2/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 4/20 0.46
HPGD P15428 7/20 0.44
HTT P42858 4/20 0.44
TP53 P04637 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
NCOA1 Q15788 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15211345 0.91 HSD17B10 (0.44) ALDH1A1HSD17B10KDM4EGAAKMT2A
SCHEMBL72974 0.89 HSD17B10 (0.50) ALDH1A1HSD17B10KDM4EGAAMEN1
SCHEMBL7422929 0.77 GLA (0.56) ALDH1A1HSD17B10KDM4EMEN1KMT2A
SCHEMBL3079300 0.77 HSD17B10 (0.68) ALDH1A1HSD17B10KDM4EGAAMEN1
SCHEMBL21223197 0.74 GAA (0.45) ALDH1A1HSD17B10KDM4EGAAMEN1
SCHEMBL19509710 0.74 ALDH1A1 (0.50) ALDH1A1HSD17B10KDM4EMEN1KMT2A
SCHEMBL1470437 0.74 MEN1 (0.57) ALDH1A1MEN1KMT2ANPSR1NPC1
SCHEMBL3947925 0.73 MEN1 (0.52) ALDH1A1HSD17B10KDM4EGAAMEN1
SCHEMBL20121222 0.73 HPGD (0.40) ALDH1A1HSD17B10KDM4EMAPTHPGD
SCHEMBL6421307 0.73 ALDH1A1 (0.54) ALDH1A1HSD17B10KDM4EGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070054902-A1 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists SHIONOGI & CO., LTD. (JP) 2007-03-08 US disclosed
EP-1690538-A1 ISOXAZOLE DERIVATIVE HAVING AGONISTIC ACTIVITY AGAINST PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR SHIONOGI & CO., LTD. (JP) 2006-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054902-A1 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists NR1H3, NR1H2, RXRA ALDH1A1 1698/4885HSD17B10 110/4885KDM4E 3202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.